Home > Insider Trading > Filing (0001144204-18-054970)

Filing Details

Accession Number:: 0001144204-18-054970
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-23 16:53:21
Reporting Period:: 2018-10-23

Accepted Time:: 2018-10-23 16:53:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1748252	Dd3 Acquisition Corp.	DDMX	Blank Checks (6770)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754381	Dd3 Mex Acquisition Corp	C/O Dd3 Acquisition Corp. Pedregal 24, Colonia Molino Del Rey Mexico City O5 11040		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2018-10-23	14,125	$0.00	1,676,625	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Warrant	Acquisiton	2018-10-23	14,125	$0.00	14,125	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
239,125			No	4	P	Direct

Footnotes

In connection with the underwriters' election to partially exercise the over-allotment option granted in connection with the Issuer's initial public offering, DD3 Mex Acquisition Corp (the "Sponsor") acquired, at a price of $10.00 per unit, 14,125 additional units (the "Private Units") for an aggregate purchase price of $141,250. Each Private Unit consists of one ordinary share and one warrant. This figure does not include an aggregate of up to 4,625 Private Units that the Sponsor has committed to purchase depending on the extent to which the remaining portion of the underwriters' option to purchase additional units is exercised.
Includes an aggregate of up to 46,250 shares subject to forfeiture by the Sponsor depending on the extent to which the remaining portion of the underwriters' option to purchase additional units is exercised.
The securities are held directly by the Sponsor and indirectly by Dr. Martin M. Werner and Jorge Combe, each of whom shares voting power with respect to the Sponsor. Certain of the Issuer's other officers and directors hold economic interests in the Sponsor and pecuniary interests in certain of the securities held by the Sponsor. Each of Dr. Werner, Mr. Combe and such other officers and directors disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or October 16, 2019.
The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation.